Bio Track at SkyDeck – Powered by QB3

Bio Track at SkyDeck – Powered by QB3

“Given UC Berkeley’s track-record of positive academic-to-commercial impact  – including being recognized by Forbes.com as ‘the #3 Startup University’ – and QB3’s nearly decade of launching life sciences startups, I can think of no more well-suited partners,” said Amy E. Herr, Ph.D., Lloyd Distinguished Professor of Bioengineering at UC Berkeley and Investigator at the Chan Zuckerberg Biohub. “From our undergraduates to our faculty, I look forward to the bright future this partnership will create.”

The Bio Track at SkyDeck – Powered by QB3 provides practical resources focused on addressing many of these challenges. Every six months, at least two companies will be selected for inclusion in SkyDeck’s Bio Track. Startups accepted into the Bio Track will receive the following:

  • $100k in equity investment from the Berkeley SkyDeck Fund;
  • Up to 12 months resident access to Berkeley SkyDeck;
  • Up to 12 months of sponsored access to bench top space at a local lab (depending on availability and specific needs);
  • Regular support from scientists and investors with a proven history in entrepreneurship in the bio sciences;
  • Bi-monthly dinner sessions with advisors / mentors with expertise in the life science space;
  • Focused introductions to investors and partners in the life science space;
  • … and of course, access to all of the other resources provided by the Berkeley SkyDeck accelerator.

 

Some FAQ’s about the Bio Track:

What kind of companies are you looking for?

  • Companies accepted into Berkeley SkyDeck on the Bio Track should be working on commercially-viable startups in any aspect of the life sciences requiring wet-lab space, ranging from diagnostics, to synthetic biology, to scientific instruments, to therapeutics.

What if I’m working on digital health / AI / computational biology / medical device?

  • We’d love to see you apply! If you don’t need access to lab space, you could be accepted under the default cohort evaluation process as well.

Am I too early / too late for the Bio Track?

  • We’re looking for startups that are up-to 12 months away from raising from institutional VC investors. For a therapeutic company, if you have a clear plan for a specific set of proof-of-concept in-vivo experiments, you’re probably at the right stage to apply.